Aug. 7, 2013
/PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) today announced the closing of its previously announced underwritten public offering of 9,000,000 shares of its common stock, as well as 1,350,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriters.
The shares were sold at the public offering price of
per share and the company estimates the aggregate net proceeds to the company will be approximately
, after deducting underwriting discounts and commissions and other estimated offering expenses.
Lazard Capital Markets LLC and Oppenheimer & Co. Inc. acted as joint book-runners for the offering. JMP Securities LLC and Maxim Group LLC served as co-managers for the offering.
The shares described above were issued pursuant to a prospectus supplement and accompanying prospectus, all as filed as part of a shelf registration statement on Form S-3 previously filed with and declared effective by the Securities and Exchange Commission ("SEC"). Copies of the prospectus supplement and the accompanying prospectus may be obtained by sending a request to: Lazard Capital Markets LLC, at 30 Rockefeller Plaza,
New York, NY
10020 or via telephone at (800) 542-0970, or Oppenheimer & Co. Inc., Attn: Syndicate Department, at 85 Broad Street, 26th Floor,
New York, NY
10004 or via email at
or via telephone at (212) 667-8563. The company filed a final prospectus supplement relating to the offering with the SEC on
August 2, 2013
, which is available along with the accompanying prospectus filed with the SEC in connection with the shelf registration, on the SEC's website at
This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities of Organovo, nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. This press release is being issued pursuant to and in accordance with Rule 134 under the Securities Act of 1933, as amended.